Search This Blog

Thursday, August 2, 2018

Regeneron reports Q2 EPS $5.45, consensus $4.70


Regeneron reports Q2 EPS $5.45, consensus $4.70  Reports Q2 revenue $1.61B, consensus $1.56B. Reports Eylea Injection U.S. net sales up 8% to 992M. Q2 Eylea global net sales up 13% to $1.66B.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)